Edward D. Sturrock

6.0k total citations · 2 hit papers
128 papers, 4.7k citations indexed

About

Edward D. Sturrock is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Edward D. Sturrock has authored 128 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Molecular Biology, 48 papers in Cardiology and Cardiovascular Medicine and 39 papers in Oncology. Recurrent topics in Edward D. Sturrock's work include Renin-Angiotensin System Studies (44 papers), Peptidase Inhibition and Analysis (37 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (28 papers). Edward D. Sturrock is often cited by papers focused on Renin-Angiotensin System Studies (44 papers), Peptidase Inhibition and Analysis (37 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (28 papers). Edward D. Sturrock collaborates with scholars based in South Africa, United Kingdom and United States. Edward D. Sturrock's co-authors include K. Ravi Acharya, Sylva L. U. Schwager, R. Natesh, Mario R. Ehlers, James Riordan, Geoffrey Masuyer, Hazel Corradi, Nigel M. Hooper, Aloysius T. Nchinda and Pierre Redelinghuys and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Edward D. Sturrock

125 papers receiving 4.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Crystal structure of the human angiotensin-converting enzyme–lisinopril complex

2003 712 citations R. Natesh, Sylva L. U. Schwager et al. profile →
Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure

2019 248 citations Mario R. Ehlers, Edward D. Sturrock et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edward D. Sturrock South Africa	34	3.0k	1.3k	870	691	504	128	4.7k
Miguel A. Ondetti United States	30	4.4k 1.5×	1.0k 0.8×	457 0.5×	807 1.2×	919 1.8×	54	6.0k
David W. Cushman Malaysia	30	6.0k 2.0×	1.7k 1.3×	552 0.6×	1.1k 1.6×	1.6k 3.1×	45	8.4k
Bernard Rubin United States	24	2.0k 0.7×	998 0.8×	195 0.2×	385 0.6×	269 0.5×	63	3.6k
Edward G. Mimnaugh United States	41	5.5k 1.9×	360 0.3×	410 0.5×	1.4k 2.0×	106 0.2×	81	7.6k
Joseph R. Kahn United States	27	1.8k 0.6×	1.3k 0.9×	118 0.1×	330 0.5×	185 0.4×	39	3.2k
Peter J. Tummino United States	34	2.7k 0.9×	761 0.6×	302 0.3×	614 0.9×	12 0.0×	76	4.8k
Stefano Costanzi United States	39	2.7k 0.9×	143 0.1×	642 0.7×	249 0.4×	58 0.1×	148	4.5k
Donald Blumenthal United States	35	3.6k 1.2×	581 0.4×	213 0.2×	276 0.4×	42 0.1×	88	5.0k
Fabrizio Giordanetto Sweden	29	2.7k 0.9×	305 0.2×	789 0.9×	524 0.8×	15 0.0×	73	4.1k
Denis Riendeau Canada	43	2.0k 0.7×	352 0.3×	172 0.2×	477 0.7×	68 0.1×	112	6.1k

Countries citing papers authored by Edward D. Sturrock

Since Specialization

Citations

This map shows the geographic impact of Edward D. Sturrock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward D. Sturrock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward D. Sturrock more than expected).

Fields of papers citing papers by Edward D. Sturrock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward D. Sturrock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward D. Sturrock. The network helps show where Edward D. Sturrock may publish in the future.

Co-authorship network of co-authors of Edward D. Sturrock

This figure shows the co-authorship network connecting the top 25 collaborators of Edward D. Sturrock. A scholar is included among the top collaborators of Edward D. Sturrock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward D. Sturrock. Edward D. Sturrock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cozier, Gyles E., et al.. (2025). Molecular basis of human angiotensin‐1 converting enzyme inhibition by a series of diprolyl‐derived compounds. FEBS Journal. 292(5). 1141–1158.

Acharya, K. Ravi, et al.. (2024). Advances in the structural basis for angiotensin-1 converting enzyme (ACE) inhibitors. Bioscience Reports. 44(8). 18 indexed citations

Ganief, Tariq, et al.. (2024). Proteomic Analysis of Human Macrophages Overexpressing Angiotensin-Converting Enzyme. International Journal of Molecular Sciences. 25(13). 7055–7055.

Sewell, B.T., et al.. (2022). Cryo‐EM reveals mechanisms of angiotensin I‐converting enzyme allostery and dimerization. The EMBO Journal. 41(16). e110550–e110550. 15 indexed citations

Cozier, Gyles E., et al.. (2022). Structural basis for the inhibition of human angiotensin‐1 converting enzyme by fosinoprilat. FEBS Journal. 289(21). 6659–6671. 3 indexed citations

Cozier, Gyles E., et al.. (2017). The Design and Development of a Potent and Selective Novel Diprolyl Derivative That Binds to the N-Domain of Angiotensin-I Converting Enzyme. Journal of Medicinal Chemistry. 61(1). 344–359. 24 indexed citations

Jones, Erika, Maia Lesosky, Sandra Castel, et al.. (2017). Therapeutic drug monitoring of amlodipine and the Z-FHL/HHL ratio: Adherence tools in patients referred for apparent treatment-resistant hypertension. South African Medical Journal. 107(10). 887–887. 7 indexed citations

Masuyer, Geoffrey, et al.. (2016). Kinetic and structural characterization of amyloid‐β peptide hydrolysis by human angiotensin‐1‐converting enzyme. FEBS Journal. 283(6). 1060–1076. 18 indexed citations

Masuyer, Geoffrey, Christopher J. Yates, Edward D. Sturrock, & K. Ravi Acharya. (2014). Angiotensin-I converting enzyme (ACE): structure, biological roles, and molecular basis for chloride ion dependence. Biological Chemistry. 395(10). 1135–1149. 42 indexed citations

10.

Danilov, S M, Ken Gordon, Andrew B. Nesterovitch, et al.. (2011). Angiotensin I-converting enzyme mutation (Y465D) cause dramatic increase in blood ACE via accelerated ACE shedding due to changes of ACE dimerization. PLoS ONE. 6(10). 25952–25952. 3 indexed citations

11.

Corradi, Hazel, Anne V. Corrigall, Ester Boix, et al.. (2006). Crystal Structure of Protoporphyrinogen Oxidase from Myxococcus xanthus and Its Complex with the Inhibitor Acifluorfen. Journal of Biological Chemistry. 281(50). 38625–38633. 57 indexed citations

12.

Nchinda, Aloysius T., Kelly Chibale, Pierre Redelinghuys, & Edward D. Sturrock. (2006). Synthesis of novel keto-ACE analogues as domain-selective angiotensin I-converting enzyme inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(17). 4612–4615. 34 indexed citations

13.

Corradi, Hazel, Sylva L. U. Schwager, Aloysius T. Nchinda, Edward D. Sturrock, & K. Ravi Acharya. (2006). Crystal Structure of the N Domain of Human Somatic Angiotensin I-converting Enzyme Provides a Structural Basis for Domain-specific Inhibitor Design. Journal of Molecular Biology. 357(3). 964–974. 133 indexed citations

14.

Balyasnikova, Irina V., Folker E. Franke, Anthony J. Chubb, et al.. (2005). Monoclonal Antibodies 1B3 and 5C8 as Probes for Monitoring the Integrity of the C-Terminal End of Soluble Angiotensin-Converting Enzyme. Hybridoma. 24(1). 14–26. 24 indexed citations

15.

Balyasnikova, Irina V., Zenda Woodman, Ronald F. Albrecht, et al.. (2005). Localization of an N-Domain Region of Angiotensin-Converting Enzyme Involved in the Regulation of Ectodomain Shedding Using Monoclonal Antibodies. Journal of Proteome Research. 4(2). 258–267. 26 indexed citations

16.

Natesh, R., Sylva L. U. Schwager, Hazel R. Evans, Edward D. Sturrock, & K. Ravi Acharya. (2004). Structural Details on the Binding of Antihypertensive Drugs Captopril and Enalaprilat to Human Testicular Angiotensin I-Converting Enzyme ^,. Biochemistry. 43(27). 8718–8724. 234 indexed citations

17.

Acharya, K. Ravi, Edward D. Sturrock, James Riordan, & Mario R. Ehlers. (2003). Ace revisited: A new target for structure-based drug design. Nature Reviews Drug Discovery. 2(11). 891–902. 259 indexed citations

18.

Schwager, Sylva L. U., Anthony J. Chubb, Renate R. Scholle, et al.. (1998). Phorbol Ester-Induced Juxtamembrane Cleavage of Angiotensin-Converting Enzyme Is Not Inhibited by a Stalk Containing Intrachain Disulfides. Biochemistry. 37(44). 15449–15456. 14 indexed citations

19.

Ged, Cécile, et al.. (1995). Identification of Two NewMutations in CongenitalErythropoietic Porphyria. European Journal of Human Genetics. 3(2). 102–107. 19 indexed citations

20.

Sturrock, Edward D., James R. Bull, Ralph E. Kirsch, et al.. (1993). A novel 2,18-bridged biliverdin derivative. Journal of the Chemical Society Chemical Communications. 872–872. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact